Inflammatory manifestations of lymphedema
Open accessAbstract
Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary malignancy. Collectively, these morbidities contribute to an overall poor quality of life. Although there have been recent advances in microsurgical interventions, a conservative palliative approach remains the mainstay of treatment for this disabling disease. The absence of a cure is due to an incomplete understanding of the pathophysiological changes that result in lymphedema. A histological hallmark of lymphedema is inflammatory cell infiltration and recent studies with animal models and clinical biopsy specimens have suggested that this response plays a key role in the pathology of the disease. The purpose of this report is to provide an overview of the ongoing research in and the current understanding of the inflammatory manifestations of lymphedema.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A common manifestation of lymphatic insufficiency is tissue fibrosis, and its progression may in turn further impair lymphatic function.
“A common manifestation of lymphatic insufficiency is tissue fibrosis, and its progression may in turn further impair lymphatic function (139).”
From Transport and Immune Functions of the Lymphatic System. (2025) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765 · see citing works
Avraham, T., Zampell, J. C., Yan, A., Elhadad, S., Weitman, E. S., Rockson, S. G., Bromberg, J., & Mehrara, B. J. (2013) · The FASEB Journal · doi:10.1096/fj.12-222695 · Cited by 241 · see citing works
Self-citationTh2 cytokines inhibit lymphangiogenesis
Savetsky, I. L., Ghanta, S., Gardenier, J. C., Torrisi, J. S., García Nores, G. D., Hespe, G. E., Nitti, M. D., Kataru, R. P., & Mehrara, B. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126908 · Cited by 114 · see citing works
Self-citationInhibition of inflammation and iNOS improves lymphatic function in obesity
Torrisi, J. S., Hespe, G. E., Cuzzone, D. A., Savetsky, I. L., Nitti, M. D., Gardenier, J. C., García Nores, G. D., Jowhar, D., Kataru, R. P., & Mehrara, B. J. (2016) · Scientific Reports · doi:10.1038/srep19817 · Cited by 97 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 74
- [1]Warren A.G. Brorson H. Borud L.J. Slavin S.A. Lymphedema: A comprehensive review Ann. Plast. Surg. 2007 59 464 472 10.1097/01.sap.0000257149.42922.7e 17901744 · DOI
- [2]DiSipio T. Rye S. Newman B. Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis Lancet Oncol. 2013 14 500 515 10.1016/S1470-2045(13)70076-7 23540561 · DOI
- [3]Cormier J.N. Askew R.L. Mungovan K.S. Xing Y. Ross M.I. Armer J.M. Lymphedema beyond breast cancer: A systematic review and meta-analysis of cancer-related secondary lymphedema Cancer 2010 116 5138 5149 10.1002/cncr.25458 20665892 · DOI
- [4]Brayton K.M. Hirsch A.T. O’Brien P.J. Cheville A. Karaca-Mandic P. Rockson S.G. Lymphedema prevalence and treatment benefits in cancer: Impact of a therapeutic intervention on health outcomes and costs PLoS ONE 2014 9 e114597 10.1371/journal.pone.0114597 25470383 PMC4255037 · DOI
- [5]Huang T.W. Tseng S.H. Lin C.C. Bai C.H. Chen C.S. Hung C.S. Wu C.H. Tam K.W. Effects of manual lymphatic drainage on breast cancer-related lymphedema: A systematic review and meta-analysis of randomized controlled trials World J. Surg. Oncol. 2013 11 15 10.1186/1477-7819-11-15 23347817 PMC3562193 · DOI
- [6]Chang D.W. Masia J. Garza R. Skoracki R. Neligan P.C. Lymphedema: Surgical and medical therapy Plast. Reconstr. Surg. 2016 138 209 218 10.1097/PRS.0000000000002683 27556764 · DOI
- [7]Torrisi J.S. Joseph W.J. Ghanta S. Cuzzone D.A. Albano N.J. Savetsky I.L. Gardenier J.C. Skoracki R. Chang D. Mehrara B.J. Lymphaticovenous bypass decreases pathologic skin changes in upper extremity breast cancer-related lymphedema Lymphat. Res. Biol. 2015 13 46 53 10.1089/lrb.2014.0022 25521197 PMC4365441 · DOI
- [8]Damstra R.J. Voesten H.G. van Schelven W.D. van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature Breast Cancer Res. Treat. 2009 113 199 206 10.1007/s10549-008-9932-5 18270813 · DOI
- [9]Granzow J.W. Soderberg J.M. Kaji A.H. Dauphine C. Review of current surgical treatments for lymphedema Ann. Surg. Oncol. 2014 21 1195 1201 10.1245/s10434-014-3518-8 24558061 · DOI
- [10]Olszewski W.L. Pathophysiological aspects of lymphedema of human limbs: I. Lymph protein composition Lymphat. Res. Biol. 2003 1 235 243 10.1089/153968503768330265 15624440 · DOI
- [11]Cemal Y. Pusic A. Mehrara B.J. Preventative measures for lymphedema: Separating fact from fiction J. Am. Coll. Surg. 2011 213 543 551 10.1016/j.jamcollsurg.2011.07.001 21802319 PMC3652571 · DOI
- [12]Petrek J.A. Senie R.T. Peters M. Rosen P.P. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis Cancer 2001 92 1368 1377 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9 11745212 · DOI
- [13]Fu M.R. Conley Y.P. Axelrod D. Guth A.A. Yu G. Fletcher J. Zagzag D. Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction Breast 2016 29 231 240 10.1016/j.breast.2016.06.023 27460425 PMC5014618 · DOI
- [14]Asdourian M.S. Skolny M.N. Brunelle C. Seward C.E. Salama L. Taghian A.G. Precautions for breast cancer-related lymphoedema: Risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis Lancet Oncol. 2016 17 392 405 10.1016/S1470-2045(16)30204-2 27599144 · DOI
- [15]Kilbreath S.L. Refshauge K.M. Beith J.M. Ward L.C. Ung O.A. Dylke E.S. French J.R. Yee J. Koelmeyer L. Gaitatzis K. Risk factors for lymphoedema in women with breast cancer: A large prospective cohort Breast (Edinburgh, Scotland) 2016 28 29 36 10.1016/j.breast.2016.04.011 27183497 · DOI
- [16]Gaffney R.M. Casley-Smith J.R. Excess plasma proteins as a cause of chronic inflammation and lymphoedema: Biochemical estimations J. Pathol. 1981 133 229 242 10.1002/path.1711330306 7463212 · DOI
- [17]Grizzle W.E. Bell W.C. Sexton K.C. Issues in collecting, processing and storing human tissues and associated information to support biomedical research Cancer Biomark. 2010 9 531 549 22112494 PMC3445033
- [18]Frueh F.S. Gousopoulos E. Rezaeian F. Menger M.D. Lindenblatt N. Giovanoli P. Animal models in surgical lymphedema research—A systematic review J. Surg. Res. 2016 200 208 220 10.1016/j.jss.2015.07.005 26235906 · DOI
- [19]Shin W.S. Rockson S.G. Animal models for the molecular and mechanistic study of lymphatic biology and disease Ann. N. Y. Acad Sci. 2008 1131 50 74 10.1196/annals.1413.005 18519959 · DOI
- [20]Olszewski W. Machowski Z. Sokolowski J. Nielubowicz J. Experimental lymphedema in dogs J. Cardiovasc. Surg. 1968 9 178 183 5660699
- [21]Rutkowski J.M. Moya M. Johannes J. Goldman J. Swartz M.A. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9 Microvasc. Res. 2006 72 161 171 10.1016/j.mvr.2006.05.009 16876204 PMC2676671 · DOI
- [22]Zampell J.C. Yan A. Elhadad S. Avraham T. Weitman E. Mehrara B.J. CD4+ cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis PLoS ONE 2012 7 e49940 10.1371/journal.pone.0049940 23185491 PMC3502174 · DOI · Paper page
- [23]Avraham T. Daluvoy S. Zampell J. Yan A. Haviv Y.S. Rockson S.G. Mehrara B.J. Blockade of transforming growth factor-β1 accelerates lymphatic regeneration during wound repair Am. J. Pathol. 2010 177 3202 3214 10.2353/ajpath.2010.100594 21056998 PMC2993295 · DOI
- [24]Clavin N.W. Avraham T. Fernandez J. Daluvoy S.V. Soares M.A. Chaudhry A. Mehrara B.J. TGF-β1 is a negative regulator of lymphatic regeneration during wound repair Am. J. Physiol. Heart Circ. Physiol. 2008 295 2113 2127 10.1152/ajpheart.00879.2008 18849330 · DOI
- [25]Tabibiazar R. Cheung L. Han J. Swanson J. Beilhack A. An A. Dadras S.S. Rockson N. Joshi S. Wagner R. Inflammatory manifestations of experimental lymphatic insufficiency PLoS Med. 2006 3 e254 10.1371/journal.pmed.0030254 16834456 PMC1502157 · DOI
- [26]Hadamitzky C. Pabst R. Acquired lymphedema: An urgent need for adequate animal models Cancer Res. 2008 68 343 345 10.1158/0008-5472.CAN-07-2454 18199525 · DOI
- [27]Schneider M. Ny A. Ruiz de Almodovar C. Carmeliet P. A new mouse model to study acquired lymphedema PLoS Med. 2006 3 e264 10.1371/journal.pmed.0030264 16842020 PMC1513046 · DOI
- [28]Blum K.S. Proulx S.T. Luciani P. Leroux J.C. Detmar M. Dynamics of lymphatic regeneration and flow patterns after lymph node dissection Breast Cancer Res. Treat. 2013 139 81 86 10.1007/s10549-013-2537-7 23613202 · DOI
- [29]Zampell J.C. Yan A. Avraham T. Andrade V. Malliaris S. Aschen S. Rockson S.G. Mehrara B.J. Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema Am. J. Physiol. Cell Physiol. 2011 300 1107 1121 10.1152/ajpcell.00378.2010 21248077 PMC3093946 · DOI
- [30]Gardenier J.C. Hespe G.E. Kataru R.P. Savetsky I.L. Torrisi J.S. Garcia Nores G.D. Dayan J.J. Chang D. Zampell J. Martinez-Corral I. Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema JCI Insight 2016 1 e84095 10.1172/jci.insight.84095 27699240 PMC5033805 · DOI
- [31]Hosking B. Makinen T. Lymphatic vasculature: A molecular perspective Bioessays 2007 29 1192 1202 10.1002/bies.20672 18008374 · DOI
- [32]Venero Galanternik M. Stratman A.N. Jung H.M. Butler M.G. Weinstein B.M. Building the drains: The lymphatic vasculature in health and disease Wiley Interdiscip. Rev. Dev. Biol. 2016 5 689 710 10.1002/wdev.246 27576003 · DOI
- [33]Hull M.M. Lymphedema in women treated for breast cancer Semin. Oncol. Nurs. 2000 16 226 237 10.1053/sonc.2000.8117 10967795 · DOI
- [34]Sakorafas G.H. Peros G. Cataliotti L. Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer Surg. Oncol. 2006 15 153 165 10.1016/j.suronc.2006.11.003 17187979 · DOI
- [35]Rutkowski J.M. Swartz M.A. A driving force for change: Interstitial flow as a morphoregulator Trends Cell Biol. 2007 17 44 50 10.1016/j.tcb.2006.11.007 17141502 · DOI
- [36]Foldi E. Sauerwald A. Hennig B. Effect of complex decongestive physiotherapy on gene expression for the inflammatory response in peripheral lymphedema Lymphology 2000 33 19 23 10769812
- [37]Rockson S.G. The lymphatics and the inflammatory response: Lessons learned from human lymphedema Lymphat. Res. Biol. 2013 11 117 120 10.1089/lrb.2013.1132 24024576 PMC3780325 · DOI
- [38]Leung G. Baggott C. West C. Elboim C. Paul S.M. Cooper B.A. Abrams G. Dhruva A. Schmidt B.L. Kober K. Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery Lymphat. Res. Biol. 2014 12 10 22 10.1089/lrb.2013.0024 24502445 PMC3961780 · DOI
- [39]Lin S. Kim J. Lee M.J. Roche L. Yang N.L. Tsao P.S. Rockson S.G. Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: Identification and validation of a circulating biomarker panel PLoS ONE 2012 7 e52021 10.1371/journal.pone.0052021 23272198 PMC3525657 · DOI
- [40]Zampell J.C. Elhadad S. Avraham T. Weitman E. Aschen S. Yan A. Mehrara B.J. Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury Am. J. Physiol. Cell Physiol. 2012 302 709 719 10.1152/ajpcell.00284.2011 22049214 PMC3287358 · DOI
- [42]Ghanta S. Cuzzone D.A. Torrisi J.S. Albano N.J. Joseph W.J. Savetsky I.L. Gardenier J.C. Chang D. Zampell J.C. Mehrara B.J. Regulation of inflammation and fibrosis by macrophages in lymphedema Am. J. Physiol. Heart Circ. Physiol. 2015 308 1065 1077 10.1152/ajpheart.00598.2014 25724493 PMC4551121 · DOI
- [43]Ogata F. Fujiu K. Matsumoto S. Nakayama Y. Shibata M. Oike Y. Koshima I. Watabe T. Nagai R. Manabe I. Excess lymphangiogenesis cooperatively induced by macrophages and CD4+ T cells drives the pathogenesis of lymphedema J. Investig. Dermatol. 2016 136 706 714 10.1016/j.jid.2015.12.001 27015456 · DOI
- [44]Galkowska H. Olszewski W.L. Cellular composition of lymph in experimental lymphedema Lymphology 1986 19 139 145 2951567
- [45]Kataru R.P. Jung K. Jang C. Yang H. Schwendener R.A. Baik J.E. Han S.H. Alitalo K. Koh G.Y. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution Blood 2009 113 5650 5659 10.1182/blood-2008-09-176776 19346498 · DOI
- [46]Kataru R.P. Kim H. Jang C. Choi D.K. Koh B.I. Kim M. Gollamudi S. Kim Y.K. Lee S.H. Koh G.Y. T lymphocytes negatively regulate lymph node lymphatic vessel formation Immunity 2011 34 96 107 10.1016/j.immuni.2010.12.016 21256057 · DOI
- [47]Gousopoulos E. Proulx S.T. Scholl J. Uecker M. Detmar M. Prominent lymphatic vessel hyperplasia with progressive dysfunction and distinct immune cell infiltration in lymphedema Am. J. Pathol. 2016 186 2193 2203 10.1016/j.ajpath.2016.04.006 27315777 · DOI
- [48]Suami H. Pan W.R. Taylor G.I. Changes in the lymph structure of the upper limb after axillary dissection: Radiographic and anatomical study in a human cadaver Plast. Reconstr. Surg. 2007 120 982 991 10.1097/01.prs.0000277995.25009.3e 17805128 · DOI
- [49]Wynn T.A. Cellular and molecular mechanisms of fibrosis J. Pathol. 2008 214 199 210 10.1002/path.2277 18161745 PMC2693329 · DOI · Paper page
- [52]Shin K. Kataru R.P. Park H.J. Kwon B.I. Kim T.W. Hong Y.K. Lee S.H. Th2 cells and their cytokines regulate formation and function of lymphatic vessels Nat. Commun. 2015 6 6196 10.1038/ncomms7196 25648335 · DOI
- [53]Shao X. Liu C. Influence of IFN-α and IFN-γ on lymphangiogenesis J. Interferon Cytokine Res. 2006 26 568 574 10.1089/jir.2006.26.568 16881867 · DOI
- [54]Oka M. Iwata C. Suzuki H.I. Kiyono K. Morishita Y. Watabe T. Komuro A. Kano M.R. Miyazono K. Inhibition of endogenous TGF-β signaling enhances lymphangiogenesis Blood 2008 111 4571 4579 10.1182/blood-2007-10-120337 18310502 · DOI
- [55]Narushima M. Yamamoto T. Ogata F. Yoshimatsu H. Mihara M. Koshima I. Indocyanine green lymphography findings in limb lymphedema J. Reconstr. Microsurg. 2016 32 72 79 26422172
- [56]Gousopoulos E. Proulx S.T. Bachmann S.B. Scholl J. Dionyssiou D. Demiri E. Halin C. Dieterich L.C. Detmar M. Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function JCI Insight 2016 1 e89081 10.1172/jci.insight.89081 27734032 PMC5054740 · DOI
- [57]Wammes L.J. Hamid F. Wiria A.E. Wibowo H. Sartono E. Maizels R.M. Smits H.H. Supali T. Yazdanbakhsh M. Regulatory T cells in human lymphatic filariasis: Stronger functional activity in microfilaremics PLoS Negl. Trop. Dis. 2012 6 e1655 10.1371/journal.pntd.0001655 22666510 PMC3362610 · DOI
- [58]Josefowicz S.Z. Lu L.F. Rudensky A.Y. Regulatory T cells: Mechanisms of differentiation and function Annu. Rev. Immunol. 2012 30 531 564 10.1146/annurev.immunol.25.022106.141623 22224781 PMC6066374 · DOI · Paper page
- [59]Mehrara B.J. Zampell J.C. Suami H. Chang D.W. Surgical management of lymphedema: Past, present, and future Lymphat. Res. Biol. 2011 9 159 167 10.1089/lrb.2011.0011 22066746 · DOI
- [60]Sharkey A.R. King S.W. Ramsden A.J. Furniss D. Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency? Microsurgery 2016 10.1002/micr.30115 27661464 · DOI
- [61]Wynn T.A. Barron L. Macrophages: Master regulators of inflammation and fibrosis Semin. Liver Dis. 2010 30 245 257 10.1055/s-0030-1255354 20665377 PMC2924662 · DOI · Paper page
- [62]Mills C.D. M1 and M2 macrophages: Oracles of health and disease Crit. Rev. Immunol. 2012 32 463 488 10.1615/CritRevImmunol.v32.i6.10 23428224 · DOI
- [63]Duffield J.S. Forbes S.J. Constandinou C.M. Clay S. Partolina M. Vuthoori S. Wu S. Lang R. Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair J. Clin. Investig. 2005 115 56 65 10.1172/JCI200522675 15630444 PMC539199 · DOI · Paper page
- [64]Kim H. Kataru R.P. Koh G.Y. Inflammation-associated lymphangiogenesis: A double-edged sword? J. Clin. Investig. 2014 124 936 942 10.1172/JCI71607 24590279 PMC3938274 · DOI
- [65]Kerjaschki D. Regele H.M. Moosberger I. Nagy-Bojarski K. Watschinger B. Soleiman A. Birner P. Krieger S. Hovorka A. Silberhumer G. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates J. Am. Soc. Nephrol. 2004 15 603 612 10.1097/01.ASN.0000113316.52371.2E 14978162 · DOI
- [66]Kim K.E. Koh Y.J. Jeon B.H. Jang C. Han J. Kataru R.P. Schwendener R.A. Kim J.M. Koh G.Y. Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm Am. J. Pathol. 2009 175 1733 1745 10.2353/ajpath.2009.090133 19762711 PMC2751568 · DOI
- [67]Kerjaschki D. The crucial role of macrophages in lymphangiogenesis J. Clin. Investig. 2005 115 2316 2319 10.1172/JCI26354 16138185 PMC1193892 · DOI
- [68]Maruyama K. Ii M. Cursiefen C. Jackson D.G. Keino H. Tomita M. van Rooijen N. Takenaka H. D’Amore P.A. Stein-Streilein J. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages J. Clin. Investig. 2005 115 2363 2372 10.1172/JCI23874 16138190 PMC1193872 · DOI
- [69]Scheller J. Chalaris A. Schmidt-Arras D. Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6 Biochim. Biophys. Acta 2011 1813 878 888 10.1016/j.bbamcr.2011.01.034 21296109 · DOI · Paper page
- [70]Cuzzone D.A. Weitman E.S. Albano N.J. Ghanta S. Savetsky I.L. Gardenier J.C. Joseph W.J. Torrisi J.S. Bromberg J.F. Olszewski W.L. IL-6 regulates adipose deposition and homeostasis in lymphedema Am. J. Physiol. Heart Circ. Physiol. 2014 306 H1426 H1434 10.1152/ajpheart.01019.2013 24633552 PMC4024716 · DOI
- [71]Karlsen T.V. Karkkainen M.J. Alitalo K. Wiig H. Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema J. Physiol. 2006 574 583 596 10.1113/jphysiol.2006.108308 16675495 PMC1817763 · DOI
- [72]Scallan J.P. Davis M.J. Genetic removal of basal nitric oxide enhances contractile activity in isolated murine collecting lymphatic vessels J. Physiol. 2013 591 2139 2156 10.1113/jphysiol.2012.250662 23420659 PMC3634525 · DOI
- [73]Liao S. Cheng G. Conner D.A. Huang Y. Kucherlapati R.S. Munn L.L. Ruddle N.H. Jain R.K. Fukumura D. Padera T.P. Impaired lymphatic contraction associated with immunosuppression Proc. Natl. Acad. Sci. USA 2011 108 18784 18789 10.1073/pnas.1116152108 22065738 PMC3219138 · DOI · Paper page
- [74]Scallan J.P. Zawieja S.D. Castorena-Gonzalez J.A. Davis M.J. Lymphatic pumping: Mechanics, mechanisms and malfunction J. Physiol. 2016 594 5749 5768 10.1113/JP272088 27219461 PMC5063934 · DOI · Paper page
- [76]Angeli V. Randolph G.J. Inflammation, lymphatic function, and dendritic cell migration Lymphat. Res. Biol. 2006 4 217 228 10.1089/lrb.2006.4406 17394405 · DOI
- [77]Randolph G.J. Angeli V. Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels Nat. Rev. Immunol. 2005 5 617 628 10.1038/nri1670 16056255 · DOI · Paper page
- [78]Olszewski W.L. Engeset A. Romaniuk A. Grzelak I. Ziolkowska A. Immune cells in peripheral lymph and skin of patients with obstructive lymphedema Lymphology 1990 23 23 33 2352440
Cited by
Sorted by citations
Transport and Immune Functions of the Lymphatic System.
Davis, M. J., Zawieja, S. D., & King, P. D. (2025) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022724-104908 · Cited by 42 · see citing works
- Authors
- Ly, C., Kataru, R., & Mehrara, B.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Mehrara, Babak
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-01-17
- Volume
- 18
- Issue
- 1
- Pages
- 171
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5297803
- OpenAlex
- W2573176225
- Cited by
- 164
- References
- 4
- Citations by year
- 2026: 18 · 2025: 13 · 2024: 22 · 2023: 16 · 2022: 25 · 2021: 20 · 2020: 22 · 2019: 15 · 2018: 10 · 2017: 3
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (T32 CA9501-29, R01 HL111130-01)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Keywords
- lymphedema, lymphatic insufficiency, inflammation, inflammatory cell infiltration, secondary malignancies, lymphedema treatment, quality of life
- MeSH terms
- Animals, Dendritic Cells, Disease Models, Animal, Humans, Inflammation, Lymphatic System, Lymphedema, Macrophages, CD4-Positive T-Lymphocytes, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review